Roche Diagnostics Joins Hands with Lanwei Medicine to Deepen Precision Medicine Cooperation and Create Innovative Demonstration Benchmarks
Recently, Roche Diagnostics China and Shanghai Lanwei Medical Laboratory Co., Ltd. announced the official establishment of the Roche Diagnostics Lanwei Medical Innovation Demonstration Center. Focusing on the field of precision medicine, both sides will engage in comprehensive cooperation based on overall solutions such as nucleic acid extraction, high-throughput sequencing, and PCR detection, jointly promoting the development and implementation of applications in fields such as infection and cancer, empowering the clinical transformation and application of scientific research achievements.
Mr. Zeng Weixiong, Chairman and General Manager of Lanwei Medical, Mr. Mao Zhisen, Vice General Manager of Lanwei Medical, Dr. Liu Jianyun, Chief Scientist of Lanwei Medical, Mr. Song Chunguang, General Manager of Lanwei Medical Shanghai Company, Mr. Liu Bin, Supply Chain Director of Lanwei Medical, Mr. Wang Feng, Senior Director of Life Sciences Department at Roche Diagnostics China, Mr. Tian Zhiqiang, Senior Marketing Director of Life Sciences Department at Roche Diagnostics China, and Ms. Huang Beibei, Sales Director of Life Sciences Department at Roche Diagnostics China, attended the event together.
The cooperation between Roche Diagnostics and Lanwei Medicine has a long history and is constantly expanding and improving. During the 5th CIIE in 2022, both sides announced a strategic cooperation to promote comprehensive cooperation in the field of precision medicine. The joint construction of the Roche Diagnosis Lanwei Medical Innovation Demonstration Center this time is also a further continuation and landing of the deepening cooperation between the two sides.
![Roche Diagnostics Joins Hands with Lanwei Medicine to Deepen Precision Medicine Cooperation and Create Innovative Demonstration Benchmarks](https://a5qu.com/upload/images/048f26db66241910360b0212a6fbc4b0.jpg)
In response, Mr. Zeng Weixiong, Chairman and General Manager of Lanwei Medical, stated, "Lanwei Medical and Roche Diagnostics have a highly compatible development concept. Through strong cooperation and resource integration, Lanwei Medical aims to create an international and professional precision medicine innovation and transformation platform, help improve innovation and research capabilities and testing levels in the field of precision medicine, effectively enhance the effectiveness of scientific and technological achievements transformation, comprehensively practice the positioning of 'effective supplements to medical institutions', promote technological innovation, and empower high-quality academic development."
Mr. Zeng Weixiong from Lanwei Medical
"Having been deeply rooted in China for more than 20 years, Roche Diagnostics has always adhered to the concept of 'in China, for China', and is committed to working with excellent local industry partners to jointly promote innovative development in the field of precision medicine. Mr. Wang Feng, Senior Director of Roche Diagnostics China - Department of Life Sciences, said," We are pleased to work together with Lanwei Medical to build an innovation demonstration center and open a new chapter of cooperation between the two sides. We will take this opportunity to build an innovation ecosystem of localized cooperation, improve the accessibility of precision medicine research, better meet the needs of the Chinese market, and benefit more Chinese patients. "
![Roche Diagnostics Joins Hands with Lanwei Medicine to Deepen Precision Medicine Cooperation and Create Innovative Demonstration Benchmarks](https://a5qu.com/upload/images/9675a2beedd17db8ff50066b8e81f68e.jpg)
Mr. Wang Feng, diagnosed by Roche
It is reported that with the landing of the "Innovation Demonstration Center", the two sides will adhere to the principle of "complementary advantages and mutual benefit" on the basis of previous cooperation, driven by innovation, and based on the application and development of high sensitivity and stable digital PCR detection technology, as well as scientific research transformation in the field of precise tumor detection. Around the fields of cancer, including lung cancer and bile duct cancer, cell gene therapy, and residual detection of small lesions, we will carry out multi-dimensional cooperation such as product and academic promotion, technical exchange, new product clinical trials, and scientific research expansion, and contribute to the development of life science research, clinical transformation, and other fields.